ATE384722T1 - Alkoxypyridinderivate - Google Patents

Alkoxypyridinderivate

Info

Publication number: ATE384722T1
Authority: AT; Austria
Prior art keywords: alkoxypyridine; derivatives; alkoxypyridine derivatives; purin; imidazo
Prior art date: 2002-03-27

Application number

AT03744851T

Other languages

English (en)

Inventor

Wolf-Ruediger Ulrich

Rainer Boer

Degenhard Marx

Manfrid Eltze

Thomas Klein

Ruediger Nave

Ulrich Graedler

Thomas Fuchss

Johannes Barsig

Original Assignee

Nycomed Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2003-03-25

Publication date

2008-02-15

2003-03-25 Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh

2008-02-15 Application granted granted Critical

2008-02-15 Publication of ATE384722T1 publication Critical patent/ATE384722T1/de

Links

-1 3H-imidazo[4,5-b]pyridin-2-yl Chemical group 0.000 abstract 4
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
102100029438 Nitric oxide synthase, inducible Human genes 0.000 abstract 1
101710089543 Nitric oxide synthase, inducible Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

AT03744851T 2002-03-27 2003-03-25 Alkoxypyridinderivate ATE384722T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02007049		2002-03-27

Publications (1)

Publication Number	Publication Date
ATE384722T1 true ATE384722T1 (de)	2008-02-15

Family

ID=28051741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03744851T ATE384722T1 (de)	2002-03-27	2003-03-25	Alkoxypyridinderivate

Country Status (18)

Country	Link
US (1)	US7138399B2 (de)
EP (1)	EP1490366B1 (de)
JP (1)	JP4448695B2 (de)
KR (1)	KR20050002910A (de)
CN (1)	CN1307176C (de)
AT (1)	ATE384722T1 (de)
AU (1)	AU2003226706A1 (de)
BR (1)	BR0308785A (de)
CA (1)	CA2480385A1 (de)
DE (1)	DE60318826T2 (de)
ES (1)	ES2300599T3 (de)
IL (1)	IL163625A0 (de)
MX (1)	MXPA04009283A (de)
NO (1)	NO20044633L (de)
NZ (1)	NZ535959A (de)
PL (1)	PL372409A1 (de)
WO (1)	WO2003080607A1 (de)
ZA (1)	ZA200407766B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0415034A (pt) *	2003-10-01	2006-12-12	Altana Pharma Ag	derivados de aminopiridina como inibidores de não-sintase induzìveis
EA010261B1 (ru) *	2003-10-01	2008-06-30	Алтана Фарма Аг	Производные имидазопиридина как ингибиторы индуцируемой no - синтазы
CA2540242A1 (en) *	2003-10-01	2005-04-07	Altana Pharma Ag	Imidazopyridine-derivatives as inducible no-synthase inhibitors
AU2004276014A1 (en)	2003-10-01	2005-04-07	Altana Pharma Ag	Imidazopyridine-derivatives as inducible no-synthase inhibitors
ATE398617T1 (de) *	2003-10-01	2008-07-15	Nycomed Gmbh	Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase
US8088935B2 (en)	2003-12-23	2012-01-03	Ironwood Pharmaceuticals, Inc.	Compounds and methods for the treatment of asthma
PL1753512T3 (pl)	2004-05-28	2009-03-31	4Sc Ag	Tetrahydropirydotiofeny
WO2005120642A2 (en)	2004-06-11	2005-12-22	Altana Pharma Ag	Tetrahydropyridothiophenes for treating hyperproliferative disorders
CA2596202A1 (en)	2005-02-09	2006-08-17	Altana Pharma Ag	Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
US7741488B2 (en)	2005-02-11	2010-06-22	4Sc Ag	Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer
US7790710B2 (en)	2005-03-31	2010-09-07	Nycomed Gmbh	Imidazopyridine derivatives useful as iNOS inhibitors
US7763728B2 (en)	2005-05-25	2010-07-27	4Sc Ag	Tetrahydropyridothiophenes
US7714136B2 (en)	2005-05-25	2010-05-11	4Sc Ag	Tetrahydropyridothiophenes
AR057525A1 (es) *	2005-10-03	2007-12-05	Astrazeneca Ab	Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion
UY29825A1 (es) *	2005-10-03	2007-05-31	Astrazeneca Ab	Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones
WO2008031788A1 (en) *	2006-09-12	2008-03-20	Nycomed Gmbh	Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase
US20080139608A1 (en) *	2006-12-06	2008-06-12	Universiteit Leiden	2,6,8, Trisubstituted 1-deazapurines and their different uses
MX348131B (es) *	2011-02-25	2017-05-26	Merck Sharp & Dohme	Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos.
WO2013011932A1 (ja)	2011-07-15	2013-01-24	塩野義製薬株式会社	Ａｍｐｋ活性化作用を有するアザベンズイミダゾール誘導体
GB201512635D0 (en)	2015-07-17	2015-08-26	Ucl Business Plc	Uses of therapeutic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE418966B (sv)	1974-02-18	1981-07-06	Haessle Ab	Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
GB8307865D0 (en) *	1983-03-22	1983-04-27	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
GB8515934D0 (en) *	1985-06-24	1985-07-24	Janssen Pharmaceutica Nv	(4-piperidinomethyl and-hetero)purines
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare

2003
- 2003-03-25 DE DE60318826T patent/DE60318826T2/de not_active Expired - Lifetime
- 2003-03-25 MX MXPA04009283A patent/MXPA04009283A/es active IP Right Grant
- 2003-03-25 PL PL03372409A patent/PL372409A1/xx not_active Application Discontinuation
- 2003-03-25 ES ES03744851T patent/ES2300599T3/es not_active Expired - Lifetime
- 2003-03-25 CN CNB038069172A patent/CN1307176C/zh not_active Expired - Fee Related
- 2003-03-25 JP JP2003578361A patent/JP4448695B2/ja not_active Expired - Fee Related
- 2003-03-25 KR KR10-2004-7015438A patent/KR20050002910A/ko not_active Ceased
- 2003-03-25 CA CA002480385A patent/CA2480385A1/en not_active Abandoned
- 2003-03-25 EP EP03744851A patent/EP1490366B1/de not_active Expired - Lifetime
- 2003-03-25 WO PCT/EP2003/003076 patent/WO2003080607A1/en not_active Ceased
- 2003-03-25 NZ NZ535959A patent/NZ535959A/en not_active IP Right Cessation
- 2003-03-25 BR BR0308785-9A patent/BR0308785A/pt not_active IP Right Cessation
- 2003-03-25 US US10/509,396 patent/US7138399B2/en not_active Expired - Fee Related
- 2003-03-25 AT AT03744851T patent/ATE384722T1/de not_active IP Right Cessation
- 2003-03-25 AU AU2003226706A patent/AU2003226706A1/en not_active Abandoned
- 2003-03-25 IL IL16362503A patent/IL163625A0/xx unknown
2004
- 2004-09-27 ZA ZA200407766A patent/ZA200407766B/en unknown
- 2004-10-27 NO NO20044633A patent/NO20044633L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1490366A1 (de)	2004-12-29
NZ535959A (en)	2006-05-26
DE60318826D1 (de)	2008-03-13
KR20050002910A (ko)	2005-01-10
US20050171125A1 (en)	2005-08-04
JP4448695B2 (ja)	2010-04-14
BR0308785A (pt)	2005-01-11
WO2003080607A1 (en)	2003-10-02
PL372409A1 (en)	2005-07-25
HK1078850A1 (en)	2006-03-24
AU2003226706A1 (en)	2003-10-08
CA2480385A1 (en)	2003-10-02
IL163625A0 (en)	2005-12-18
JP2005525388A (ja)	2005-08-25
CN1307176C (zh)	2007-03-28
MXPA04009283A (es)	2005-01-25
DE60318826T2 (de)	2009-01-22
ZA200407766B (en)	2006-06-28
NO20044633L (no)	2004-12-23
US7138399B2 (en)	2006-11-21
EP1490366B1 (de)	2008-01-23
CN1642955A (zh)	2005-07-20
ES2300599T3 (es)	2008-06-16

Legal Events

Date	Code	Title	Description
2008-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60318826D1 (de)	2008-03-13	Alkoxypyridinderivate
ATE302775T1 (de)	2005-09-15	Carbolinderivate
BR0014352A (pt)	2002-06-11	Cetoenóis espirocìclicos substituìdos por trifluormetila
ATE226208T1 (de)	2002-11-15	4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
ATE346067T1 (de)	2006-12-15	Carbolinderivate
NO20060670L (no)	2006-05-12	N3-substituerte imidazopyridin C-kit inhibitorer
ATE332903T1 (de)	2006-08-15	Kondensierte pyridoindolderivate
AR029214A1 (es)	2003-06-18	Compuestos inhibidores de fosfodiesterasa - 4: 8 - arilquinolinas sustituidas, composiciones farmaceuticas, metodo de tratamiento que las utiliza
ATE482211T1 (de)	2010-10-15	Imidazoä1,2-aüpyridin-anxiolytika
NO20061317L (no)	2006-03-23	Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
ATE333457T1 (de)	2006-08-15	Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE302776T1 (de)	2005-09-15	Kondensierte pyridoindolderivate
ATE356131T1 (de)	2007-03-15	Tricyclische imidazopyridine
ATE259813T1 (de)	2004-03-15	Triazolopyrimidinderivate
EA200600601A1 (ru)	2006-10-27	Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
DE60110124D1 (de)	2005-05-19	Kondensierte pyrazindionderivate als pde inhibitoren
DE60122559D1 (de)	2006-10-05	Indolderivate als pde5-inhibitoren
ATE335742T1 (de)	2006-09-15	Carbolinderivate als pdev inhibitoren
ATE399169T1 (de)	2008-07-15	Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase
ATE403655T1 (de)	2008-08-15	Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
NO20061343L (no)	2006-03-24	Imidazo[4,5-b]pyridinderivater som induserbare NO-syntaseinhibitorer
ATE360422T1 (de)	2007-05-15	Tetrazyklische verbindungen als pde5-inhibitoren
IS8034A (is)	2005-09-16	Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
CY1105981T1 (el)	2011-04-06	Ενωσεις 5-πυριδυλ-1,3-αζολιου, μεθοδοι παρασκευης αυτων και χρηση αυτων